Fycompa Coupons & Savings Card – Discount Prices from $212.50

Fycompa is used as an adjunctive treatment for partial-onset seizures with or without secondarily generalized seizures in patients with epilepsy. It is also used for primary generalized tonic-clonic seizures in patients with epilepsy.

Yes, Fycompa (perampanel) is classified as a Schedule III controlled substance in the United States. This classification indicates that it has a potential for abuse, although it is less than that of Schedule I and II substances.

Fycompa (perampanel) carries a black box warning for serious psychiatric and behavioral reactions. These can include aggression, hostility, irritability, anger, and homicidal ideation and threats. It is important for patients and caregivers to be aware of these potential side effects and to report any significant changes in mood or behavior to a healthcare provider immediately.

Fycompa and Keppra are not the same. They are both medications used to treat seizures, but they belong to different drug classes and have different mechanisms of action. Fycompa (perampanel) is an AMPA receptor antagonist, while Keppra (levetiracetam) is a pyrrolidine derivative. It is important for patients to follow their healthcare provider's guidance regarding the use of these medications.

Serious side effects of Fycompa (perampanel) may include severe mood changes, such as aggression, hostility, or anger, as well as suicidal thoughts or behavior. It can also cause dizziness, drowsiness, and coordination problems, which may increase the risk of falls or accidents. Additionally, some individuals may experience serious allergic reactions, such as rash, itching, swelling, severe dizziness, or trouble breathing. It is important to seek medical attention immediately if any of these serious side effects occur.